Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Recent advances in gut microbiota metabolite regulation of hepatic pregnane X receptor.

Created on 10 Dec 2025

Authors

Tong Lin, Yang Chen, Linquan Liu, Tiesong Wu, Yan Qian, Baofen Jin

Published in

Frontiers in immunology. Volume 16. Pages 1692684. Epub Nov 24, 2025.

Abstract

The pregnane X receptor (PXR), a key hepatic nuclear receptor, exhibits a highly plastic ligand-binding domain (LBD) that recognizes diverse endogenous and exogenous ligands, contributing to interindividual variations in xenobiotic metabolism and toxic responses. Emerging studies on the gut-liver axis reveal that microbiota metabolites regulate hepatic PXR through dual mechanisms: (1) Direct ligand-receptor interactions, where secondary bile acids (e.g., 3-keto LCA, DCA) and indole-3-propionic acid (IPA) bind PXR-LBD via hydrogen bonding to induce conformational changes, subsequently upregulating CYP3A4/ABCB1 expression while inhibiting NF-κB-mediated inflammation and modulating bile acid homeostasis through crosstalk with the farnesoid X receptor (FXR); and (2) Epigenetic reprogramming, wherein short-chain fatty acids (SCFAs) such as butyrate enhance PXR transcription by inhibiting histone deacetylase (HDAC) activity and promoting histone acetylation (e.g., at H3K9/K14 residues), thereby increasing promoter accessibility. This epigenetic mechanism contrasts with the direct ligand-binding pathway by acting indirectly through chromatin remodeling. Dysregulated PXR signaling underlies bile acid imbalance, mitochondrial dysfunction, and chemoresistance, driving clinical development of interventions including probiotic modulation of LCA/DCA balance, triptolide-mediated PXR activation, and structure-based PXR-targeted drug design. These findings highlight the microbiota-PXR axis as a critical determinant of drug response heterogeneity and a promising therapeutic target for metabolic liver disorders and refractory malignancies.

PMID:
41368631
Bibliographic data and abstract were imported from PubMed on 10 Dec 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement